# Moxonidine in Patients Undergoing Vascular Surgery

> **NCT00244504** · PHASE3 · TERMINATED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 141 (actual)

## Conditions studied

- Cardiac Disease
- Vascular Surgery

## Interventions

- **DRUG:** moxonidine

## Key facts

- **NCT ID:** NCT00244504
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-11
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 141 (ACTUAL)
- **Why stopped:** Study was stopped after pre-definied interim analysis because of no effects
- **Last updated:** 2009-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244504, "Moxonidine in Patients Undergoing Vascular Surgery". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00244504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*